Double-blind, randomized and controlled trial of EPI-743 in Friedreich's ataxia.
Zesiewicz T, Salemi JL, Perlman S, Sullivan KL, Shaw JD, Huang Y, Isaacs C, Gooch C, Lynch DR, Klein MB.
Zesiewicz T, et al. Among authors: salemi jl.
Neurodegener Dis Manag. 2018 Aug;8(4):233-242. doi: 10.2217/nmt-2018-0013. Epub 2018 Jul 27.
Neurodegener Dis Manag. 2018.
PMID: 30051753
Clinical Trial.